Lupus is an autoimmune disease. In an autoimmune disease, the body's immune system mistakes healthy tissues and organs as foreign and potentially dangerous invaders into the body and attacks them. This results in inflammation that eventually can damage and destroy the affected tissues and organs. Another study is testing a combination of two medicines. One is a standard drug and the other is a new drug. Scientists hope that the combination will be more effective and cause fewer side effects.
Extrapolation of Prevalence Rate of Lupus is 198,812 among the estimated population of 38,626,3492 in Poland. There is no cure for lupus. However, it is a myth that lupus is commonly a fatal disease. With early recognition, regular medical care, and good patient compliance with a treatment plan, it is possible for most people with lupus to live a normal lifespan. Anti-inflammatory drugs can help control arthritis symptoms; skin lesions may respond to topical treatment such as corticosteroid creams.
Medications commonly used to treat lupus include non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen (Advil) and aspirin. NSAIDs are very effective in treating the pain and inflammation of mild lupus. These include bleeding gastrointestinal ulcers and possible heart problems and cardiovascular events. Corticosteroids, such as prednisone, may also be used to reduce inflammation in lupus. Anti-malarial drugs may also be used to treat the joint pain and inflammation of lupus.
NIAMS researchers have found a gene linked to a higher risk of lupus kidney disease in African Americans. Changes in this gene keep the immune system from removing harmful germ-fighters from the body after they've done their job. Other genes may also play a role.Lupus is more common in women than in men. Researchers are looking into the role of hormones and other male-female differences. One NIAMS project is testing a new drug that scientists hope will have milder side effects than standard treatments.